Synopsis
Synopsis
0
USDMF
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1847-24-1
2. Floxacillin Sodium
3. Floxapen Sodium
4. Flucloxacillin Sodium Salt
5. Floxacillin Na Salt
6. Stafopen Sodium Salt
7. Staphylex Sodium Salt
8. Floxacillin Sodium Salt
9. Chebi:31615
10. 05f65o42vk
11. Floxapen
12. Flucloxacillin Sodium Anhydrous
13. Sodium Flucloxacillin
14. Floxapen (tn)
15. Flucloxacillin-sodium
16. Monosodium Flucloxacillin
17. Floxacillin Sodium Anhydrous
18. Mfi-pc
19. Staphylex Sodium
20. Sodium;(2s,5r,6r)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
21. Nsc277175
22. Nsc-277175
23. Einecs 217-428-0
24. Nsc 277175
25. Unii-05f65o42vk
26. Cas-1847-24-1
27. 5-methyl-3-(2-chloro-6-fluorophenyl)-4-isoxazolylpenicillin Sodium
28. Dsstox_cid_25115
29. Dsstox_rid_80681
30. Dsstox_gsid_45115
31. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, Monosodium Salt, (2s,5r,6r)-
32. Schembl855084
33. Chembl283053
34. Dtxsid6045115
35. Hy-a0246a
36. Bcp07050
37. Tox21_110054
38. Mfcd01682108
39. Akos015894891
40. Flucloxacillin Sodium [who-dd]
41. Ccg-269502
42. Cs-7130
43. Ncgc00014633-01
44. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, Monosodium Salt, (2s-(2-alpha,5-alpha,6-beta))-
45. Ac-22672
46. As-75308
47. Sodium (2s-(2alpha,5alpha,6beta))-6-(((3-(2-chloro-6-fluorophenyl)-5-methylisoxazol-4-yl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
48. C73561
49. D07965
50. A812884
51. W-107791
52. Q27114512
53. Flucloxacillin Sodium, Vetranal(tm), Analytical Standard
54. Flucloxacillin Sodium, Antibiotic For Culture Media Use Only
55. (2s,5r,6r)-6-(3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid,sodium Salt
56. (2s,5r,6r)-6-[[3-(2-chloro-6-fluoro-phenyl)-5-methyl-isoxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid; Sodium;(2s,5r,6r)-6-(3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid,sodium Salt
57. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, Sodium Salt (2s(2.alpha.,5.alpha.,6.beta.))
58. Sodium (2s,5r,6r)-6-(3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
59. Sodium (2s,5r,6r)-6-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-amido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
60. Sodium 6beta-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carboxamido]-2,2-dimethylpenam-3alpha-carboxylate
| Molecular Weight | 475.9 g/mol |
|---|---|
| Molecular Formula | C19H16ClFN3NaO5S |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 475.0380919 g/mol |
| Monoisotopic Mass | 475.0380919 g/mol |
| Topological Polar Surface Area | 141 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 764 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
Certificate Number : R1-CEP 2010-210 - Rev 04
Issue Date : 2022-08-05
Type : Chemical
Substance Number : 668
Status : Valid
Date of Issue : 2022-05-19
Valid Till : 2025-05-27
Written Confirmation Number : WC-0010
Address of the Firm :
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
Bioquim: An European GMP-certified company manufacturing bulk APIs, specializing in sterile lyophilization and chemical synthesis.
Certificate Number : R0-CEP 2005-246 - Rev 01
Issue Date : 2008-12-03
Type : Chemical
Substance Number : 668
Status : Expired
Certificate Number : CEP 2007-154 - Rev 06
Issue Date : 2023-11-30
Type : Chemical
Substance Number : 668
Status : Valid
Date of Issue : 2022-08-02
Valid Till : 2025-07-02
Written Confirmation Number : WC-0121
Address of the Firm :
Certificate Number : R1-CEP 1999-077 - Rev 03
Issue Date : 2019-03-28
Type : Chemical
Substance Number : 668
Status : Withdrawn by Holder
Certificate Number : R1-CEP 1996-093 - Rev 06
Issue Date : 2022-05-20
Type : Chemical
Substance Number : 668
Status : Valid
Certificate Number : CEP 2003-055 - Rev 11
Issue Date : 2023-11-28
Type : Chemical
Substance Number : 668
Status : Valid
Date of Issue : 2022-08-02
Valid Till : 2025-07-02
Written Confirmation Number : WC-0121
Address of the Firm :
Certificate Number : R1-CEP 1998-068 - Rev 01
Issue Date : 2006-01-06
Type : Chemical
Substance Number : 668
Status : Withdrawn by Holder
Certificate Number : CEP 1999-039 - Rev 07
Issue Date : 2024-01-17
Type : Chemical
Substance Number : 668
Status : Valid
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
91
PharmaCompass offers a list of Flucloxacillin Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Flucloxacillin Sodium manufacturer or Flucloxacillin Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Flucloxacillin Sodium manufacturer or Flucloxacillin Sodium supplier.
PharmaCompass also assists you with knowing the Flucloxacillin Sodium API Price utilized in the formulation of products. Flucloxacillin Sodium API Price is not always fixed or binding as the Flucloxacillin Sodium Price is obtained through a variety of data sources. The Flucloxacillin Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Flucloxacillin Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flucloxacillin Sodium, including repackagers and relabelers. The FDA regulates Flucloxacillin Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flucloxacillin Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Flucloxacillin Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Flucloxacillin Sodium supplier is an individual or a company that provides Flucloxacillin Sodium active pharmaceutical ingredient (API) or Flucloxacillin Sodium finished formulations upon request. The Flucloxacillin Sodium suppliers may include Flucloxacillin Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Flucloxacillin Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Flucloxacillin Sodium CEP of the European Pharmacopoeia monograph is often referred to as a Flucloxacillin Sodium Certificate of Suitability (COS). The purpose of a Flucloxacillin Sodium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Flucloxacillin Sodium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Flucloxacillin Sodium to their clients by showing that a Flucloxacillin Sodium CEP has been issued for it. The manufacturer submits a Flucloxacillin Sodium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Flucloxacillin Sodium CEP holder for the record. Additionally, the data presented in the Flucloxacillin Sodium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Flucloxacillin Sodium DMF.
A Flucloxacillin Sodium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Flucloxacillin Sodium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Flucloxacillin Sodium suppliers with CEP (COS) on PharmaCompass.
A Flucloxacillin Sodium written confirmation (Flucloxacillin Sodium WC) is an official document issued by a regulatory agency to a Flucloxacillin Sodium manufacturer, verifying that the manufacturing facility of a Flucloxacillin Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Flucloxacillin Sodium APIs or Flucloxacillin Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Flucloxacillin Sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Flucloxacillin Sodium suppliers with Written Confirmation (WC) on PharmaCompass.
Flucloxacillin Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Flucloxacillin Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Flucloxacillin Sodium GMP manufacturer or Flucloxacillin Sodium GMP API supplier for your needs.
A Flucloxacillin Sodium CoA (Certificate of Analysis) is a formal document that attests to Flucloxacillin Sodium's compliance with Flucloxacillin Sodium specifications and serves as a tool for batch-level quality control.
Flucloxacillin Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Flucloxacillin Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Flucloxacillin Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Flucloxacillin Sodium EP), Flucloxacillin Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Flucloxacillin Sodium USP).
